nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—ABCB1—hematologic cancer	0.0906	1	CbGaD
Domperidone—CYP1A2—Anagrelide—hematologic cancer	0.0239	0.0351	CbGbCtD
Domperidone—CYP2B6—Thiotepa—hematologic cancer	0.0234	0.0344	CbGbCtD
Domperidone—ABCB1—Lenalidomide—hematologic cancer	0.0145	0.0213	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0139	0.0205	CbGbCtD
Domperidone—CYP3A7—Ifosfamide—hematologic cancer	0.0139	0.0205	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0133	0.0196	CbGbCtD
Domperidone—CYP3A7—Imatinib—hematologic cancer	0.0133	0.0196	CbGbCtD
Domperidone—CYP2B6—Ifosfamide—hematologic cancer	0.0133	0.0195	CbGbCtD
Domperidone—CYP2C8—Bortezomib—hematologic cancer	0.0131	0.0193	CbGbCtD
Domperidone—CYP3A5—Daunorubicin—hematologic cancer	0.013	0.0192	CbGbCtD
Domperidone—CYP2D6—Lomustine—hematologic cancer	0.0127	0.0187	CbGbCtD
Domperidone—CYP1A2—Carmustine—hematologic cancer	0.0126	0.0185	CbGbCtD
Domperidone—CYP3A5—Thalidomide—hematologic cancer	0.0119	0.0175	CbGbCtD
Domperidone—CYP2B6—Nilotinib—hematologic cancer	0.0115	0.017	CbGbCtD
Domperidone—CYP3A5—Teniposide—hematologic cancer	0.0113	0.0167	CbGbCtD
Domperidone—CYP2D6—Idarubicin—hematologic cancer	0.0113	0.0166	CbGbCtD
Domperidone—CYP1A2—Methoxsalen—hematologic cancer	0.0107	0.0157	CbGbCtD
Domperidone—CYP3A5—Ifosfamide—hematologic cancer	0.0105	0.0154	CbGbCtD
Domperidone—CYP1A2—Bortezomib—hematologic cancer	0.0102	0.0149	CbGbCtD
Domperidone—CYP2C8—Ifosfamide—hematologic cancer	0.0101	0.0148	CbGbCtD
Domperidone—CYP3A5—Imatinib—hematologic cancer	0.01	0.0147	CbGbCtD
Domperidone—CYP1A2—Daunorubicin—hematologic cancer	0.00971	0.0143	CbGbCtD
Domperidone—CYP2D6—Hydroxyurea—hematologic cancer	0.00962	0.0141	CbGbCtD
Domperidone—CYP1A2—Alitretinoin—hematologic cancer	0.00952	0.014	CbGbCtD
Domperidone—CYP1A2—Thalidomide—hematologic cancer	0.00885	0.013	CbGbCtD
Domperidone—CYP2C8—Nilotinib—hematologic cancer	0.00873	0.0128	CbGbCtD
Domperidone—CYP3A4—Bexarotene—hematologic cancer	0.00868	0.0128	CbGbCtD
Domperidone—ABCB1—Daunorubicin—hematologic cancer	0.00849	0.0125	CbGbCtD
Domperidone—CYP2D6—Bortezomib—hematologic cancer	0.00837	0.0123	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00832	0.0122	CbGbCtD
Domperidone—CYP3A7—Irinotecan—hematologic cancer	0.00832	0.0122	CbGbCtD
Domperidone—ABCB1—Alitretinoin—hematologic cancer	0.00832	0.0122	CbGbCtD
Domperidone—CYP3A4—Lomustine—hematologic cancer	0.00807	0.0119	CbGbCtD
Domperidone—CYP3A4—Busulfan—hematologic cancer	0.00807	0.0119	CbGbCtD
Domperidone—CYP3A5—Dasatinib—hematologic cancer	0.00803	0.0118	CbGbCtD
Domperidone—CYP2B6—Irinotecan—hematologic cancer	0.00793	0.0117	CbGbCtD
Domperidone—CYP1A2—Dacarbazine—hematologic cancer	0.00761	0.0112	CbGbCtD
Domperidone—CYP1A2—Imatinib—hematologic cancer	0.00744	0.0109	CbGbCtD
Domperidone—CYP3A7—Vincristine—hematologic cancer	0.00727	0.0107	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00727	0.0107	CbGbCtD
Domperidone—CYP3A4—Thiotepa—hematologic cancer	0.00719	0.0106	CbGbCtD
Domperidone—ABCB1—Imatinib—hematologic cancer	0.00651	0.00957	CbGbCtD
Domperidone—CYP2B6—Cisplatin—hematologic cancer	0.00646	0.0095	CbGbCtD
Domperidone—CYP3A5—Irinotecan—hematologic cancer	0.00624	0.00918	CbGbCtD
Domperidone—CYP2D6—Imatinib—hematologic cancer	0.00613	0.00901	CbGbCtD
Domperidone—CYP1A2—Dasatinib—hematologic cancer	0.00598	0.00879	CbGbCtD
Domperidone—ABCB1—Nilotinib—hematologic cancer	0.00591	0.00869	CbGbCtD
Domperidone—ABCB1—Vinorelbine—hematologic cancer	0.00586	0.00862	CbGbCtD
Domperidone—CYP3A4—Methoxsalen—hematologic cancer	0.00559	0.00823	CbGbCtD
Domperidone—CYP2D6—Nilotinib—hematologic cancer	0.00557	0.00819	CbGbCtD
Domperidone—CYP2D6—Vinorelbine—hematologic cancer	0.00552	0.00812	CbGbCtD
Domperidone—CYP3A7—Dexamethasone—hematologic cancer	0.00548	0.00806	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00548	0.00806	CbGbCtD
Domperidone—CYP3A5—Vincristine—hematologic cancer	0.00546	0.00803	CbGbCtD
Domperidone—CYP3A4—Bortezomib—hematologic cancer	0.00532	0.00782	CbGbCtD
Domperidone—ABCB1—Dasatinib—hematologic cancer	0.00523	0.00768	CbGbCtD
Domperidone—CYP2B6—Dexamethasone—hematologic cancer	0.00522	0.00768	CbGbCtD
Domperidone—ABCB1—Mitoxantrone—hematologic cancer	0.00516	0.00759	CbGbCtD
Domperidone—CYP3A4—Daunorubicin—hematologic cancer	0.00509	0.00748	CbGbCtD
Domperidone—CYP3A5—Etoposide—hematologic cancer	0.005	0.00735	CbGbCtD
Domperidone—CYP2C8—Etoposide—hematologic cancer	0.00481	0.00707	CbGbCtD
Domperidone—ABCB1—Betamethasone—hematologic cancer	0.0046	0.00676	CbGbCtD
Domperidone—ABCB1—Gemcitabine—hematologic cancer	0.00456	0.0067	CbGbCtD
Domperidone—ABCB1—Prednisolone—hematologic cancer	0.00454	0.00667	CbGbCtD
Domperidone—CYP3A4—Cytarabine—hematologic cancer	0.00449	0.0066	CbGbCtD
Domperidone—CYP3A4—Teniposide—hematologic cancer	0.00442	0.0065	CbGbCtD
Domperidone—CYP2B6—Doxorubicin—hematologic cancer	0.00433	0.00637	CbGbCtD
Domperidone—ABCB1—Prednisone—hematologic cancer	0.00429	0.0063	CbGbCtD
Domperidone—CYP3A5—Dexamethasone—hematologic cancer	0.00411	0.00605	CbGbCtD
Domperidone—CYP3A4—Ifosfamide—hematologic cancer	0.00408	0.006	CbGbCtD
Domperidone—ABCB1—Irinotecan—hematologic cancer	0.00406	0.00598	CbGbCtD
Domperidone—CYP2C8—Dexamethasone—hematologic cancer	0.00395	0.00581	CbGbCtD
Domperidone—CYP3A4—Imatinib—hematologic cancer	0.0039	0.00573	CbGbCtD
Domperidone—CYP1A2—Etoposide—hematologic cancer	0.00372	0.00547	CbGbCtD
Domperidone—CYP3A4—Ruxolitinib—hematologic cancer	0.00367	0.0054	CbGbCtD
Domperidone—ABCB1—Vinblastine—hematologic cancer	0.00361	0.00531	CbGbCtD
Domperidone—ABCB1—Vincristine—hematologic cancer	0.00355	0.00522	CbGbCtD
Domperidone—CYP3A4—Nilotinib—hematologic cancer	0.00354	0.00521	CbGbCtD
Domperidone—CYP3A4—Vinorelbine—hematologic cancer	0.00351	0.00517	CbGbCtD
Domperidone—CYP2D6—Vinblastine—hematologic cancer	0.0034	0.00501	CbGbCtD
Domperidone—ABCB1—Cisplatin—hematologic cancer	0.00331	0.00487	CbGbCtD
Domperidone—ABCB1—Etoposide—hematologic cancer	0.00325	0.00479	CbGbCtD
Domperidone—CYP3A4—Triamcinolone—hematologic cancer	0.00321	0.00472	CbGbCtD
Domperidone—CYP3A4—Dasatinib—hematologic cancer	0.00313	0.0046	CbGbCtD
Domperidone—CYP3A4—Mitoxantrone—hematologic cancer	0.00309	0.00455	CbGbCtD
Domperidone—CYP3A4—Betamethasone—hematologic cancer	0.00276	0.00405	CbGbCtD
Domperidone—CYP3A4—Prednisolone—hematologic cancer	0.00272	0.004	CbGbCtD
Domperidone—ABCB1—Dexamethasone—hematologic cancer	0.00268	0.00393	CbGbCtD
Domperidone—CYP3A4—Prednisone—hematologic cancer	0.00257	0.00378	CbGbCtD
Domperidone—CYP2D6—Dexamethasone—hematologic cancer	0.00252	0.00371	CbGbCtD
Domperidone—CYP3A4—Irinotecan—hematologic cancer	0.00243	0.00358	CbGbCtD
Domperidone—ABCB1—Doxorubicin—hematologic cancer	0.00222	0.00326	CbGbCtD
Domperidone—CYP3A4—Vinblastine—hematologic cancer	0.00216	0.00318	CbGbCtD
Domperidone—ABCB1—Methotrexate—hematologic cancer	0.00215	0.00316	CbGbCtD
Domperidone—CYP3A4—Vincristine—hematologic cancer	0.00213	0.00313	CbGbCtD
Domperidone—CYP2D6—Doxorubicin—hematologic cancer	0.00209	0.00308	CbGbCtD
Domperidone—CYP3A4—Etoposide—hematologic cancer	0.00195	0.00287	CbGbCtD
Domperidone—CYP3A4—Dexamethasone—hematologic cancer	0.0016	0.00236	CbGbCtD
Domperidone—CYP3A4—Doxorubicin—hematologic cancer	0.00133	0.00196	CbGbCtD
Domperidone—KCNH2—hematopoietic system—hematologic cancer	0.000154	0.0572	CbGeAlD
Domperidone—CYP2C8—hematopoietic system—hematologic cancer	0.000141	0.0523	CbGeAlD
Domperidone—CYP1A2—hematopoietic system—hematologic cancer	0.000132	0.0489	CbGeAlD
Domperidone—CYP3A5—hematopoietic system—hematologic cancer	0.000127	0.0472	CbGeAlD
Domperidone—CYP2B6—hematopoietic system—hematologic cancer	0.000126	0.0469	CbGeAlD
Domperidone—KCNH2—blood—hematologic cancer	0.000102	0.0379	CbGeAlD
Domperidone—KCNH2—bone marrow—hematologic cancer	9.85e-05	0.0366	CbGeAlD
Domperidone—Nausea—Lenalidomide—hematologic cancer	9.83e-05	0.000587	CcSEcCtD
Domperidone—Urticaria—Mitoxantrone—hematologic cancer	9.75e-05	0.000582	CcSEcCtD
Domperidone—Pruritus—Thalidomide—hematologic cancer	9.72e-05	0.00058	CcSEcCtD
Domperidone—Diarrhoea—Thiotepa—hematologic cancer	9.72e-05	0.00058	CcSEcCtD
Domperidone—Abdominal pain—Mitoxantrone—hematologic cancer	9.7e-05	0.000579	CcSEcCtD
Domperidone—Abdominal pain—Irinotecan—hematologic cancer	9.7e-05	0.000579	CcSEcCtD
Domperidone—Nausea—Hydroxyurea—hematologic cancer	9.7e-05	0.000579	CcSEcCtD
Domperidone—Vomiting—Bortezomib—hematologic cancer	9.69e-05	0.000578	CcSEcCtD
Domperidone—Vomiting—Bleomycin—hematologic cancer	9.61e-05	0.000574	CcSEcCtD
Domperidone—Rash—Bortezomib—hematologic cancer	9.61e-05	0.000573	CcSEcCtD
Domperidone—Dermatitis—Bortezomib—hematologic cancer	9.6e-05	0.000573	CcSEcCtD
Domperidone—CYP2B6—gonad—hematologic cancer	9.59e-05	0.0357	CbGeAlD
Domperidone—Drowsiness—Methotrexate—hematologic cancer	9.58e-05	0.000572	CcSEcCtD
Domperidone—Headache—Bortezomib—hematologic cancer	9.54e-05	0.00057	CcSEcCtD
Domperidone—Hypotension—Etoposide—hematologic cancer	9.53e-05	0.000569	CcSEcCtD
Domperidone—Rash—Bleomycin—hematologic cancer	9.53e-05	0.000569	CcSEcCtD
Domperidone—CYP3A4—hematopoietic system—hematologic cancer	9.53e-05	0.0354	CbGeAlD
Domperidone—Dermatitis—Bleomycin—hematologic cancer	9.52e-05	0.000569	CcSEcCtD
Domperidone—Asthenia—Carmustine—hematologic cancer	9.47e-05	0.000565	CcSEcCtD
Domperidone—Vomiting—Vinorelbine—hematologic cancer	9.46e-05	0.000565	CcSEcCtD
Domperidone—Dry mouth—Triamcinolone—hematologic cancer	9.44e-05	0.000564	CcSEcCtD
Domperidone—Dysuria—Epirubicin—hematologic cancer	9.41e-05	0.000562	CcSEcCtD
Domperidone—Diarrhoea—Thalidomide—hematologic cancer	9.4e-05	0.000561	CcSEcCtD
Domperidone—Dizziness—Thiotepa—hematologic cancer	9.39e-05	0.000561	CcSEcCtD
Domperidone—Asthenia—Alitretinoin—hematologic cancer	9.38e-05	0.00056	CcSEcCtD
Domperidone—Rash—Vinorelbine—hematologic cancer	9.38e-05	0.00056	CcSEcCtD
Domperidone—CYP2D6—hematopoietic system—hematologic cancer	9.37e-05	0.0349	CbGeAlD
Domperidone—Dermatitis—Vinorelbine—hematologic cancer	9.37e-05	0.000559	CcSEcCtD
Domperidone—Stomatitis—Methotrexate—hematologic cancer	9.34e-05	0.000558	CcSEcCtD
Domperidone—CYP2C8—blood—hematologic cancer	9.32e-05	0.0347	CbGeAlD
Domperidone—Headache—Vinorelbine—hematologic cancer	9.32e-05	0.000556	CcSEcCtD
Domperidone—Conjunctivitis—Methotrexate—hematologic cancer	9.32e-05	0.000556	CcSEcCtD
Domperidone—Pollakiuria—Epirubicin—hematologic cancer	9.29e-05	0.000555	CcSEcCtD
Domperidone—Asthenia—Ifosfamide—hematologic cancer	9.27e-05	0.000553	CcSEcCtD
Domperidone—Oedema—Triamcinolone—hematologic cancer	9.26e-05	0.000553	CcSEcCtD
Domperidone—Pruritus—Alitretinoin—hematologic cancer	9.25e-05	0.000552	CcSEcCtD
Domperidone—Arrhythmia—Prednisone—hematologic cancer	9.2e-05	0.000549	CcSEcCtD
Domperidone—Pruritus—Ifosfamide—hematologic cancer	9.14e-05	0.000546	CcSEcCtD
Domperidone—Insomnia—Prednisolone—hematologic cancer	9.1e-05	0.000543	CcSEcCtD
Domperidone—Dizziness—Thalidomide—hematologic cancer	9.09e-05	0.000542	CcSEcCtD
Domperidone—Somnolence—Etoposide—hematologic cancer	9.07e-05	0.000542	CcSEcCtD
Domperidone—DRD2—lung—hematologic cancer	9.06e-05	0.0337	CbGeAlD
Domperidone—Nausea—Bortezomib—hematologic cancer	9.05e-05	0.00054	CcSEcCtD
Domperidone—Asthenia—Vincristine—hematologic cancer	9.04e-05	0.00054	CcSEcCtD
Domperidone—Vomiting—Thiotepa—hematologic cancer	9.03e-05	0.000539	CcSEcCtD
Domperidone—Diarrhoea—Carmustine—hematologic cancer	9.03e-05	0.000539	CcSEcCtD
Domperidone—Nausea—Bleomycin—hematologic cancer	8.98e-05	0.000536	CcSEcCtD
Domperidone—Drowsiness—Epirubicin—hematologic cancer	8.97e-05	0.000535	CcSEcCtD
Domperidone—Rash—Thiotepa—hematologic cancer	8.96e-05	0.000535	CcSEcCtD
Domperidone—Dermatitis—Thiotepa—hematologic cancer	8.95e-05	0.000534	CcSEcCtD
Domperidone—Diarrhoea—Alitretinoin—hematologic cancer	8.94e-05	0.000534	CcSEcCtD
Domperidone—Headache—Thiotepa—hematologic cancer	8.9e-05	0.000531	CcSEcCtD
Domperidone—Diarrhoea—Ifosfamide—hematologic cancer	8.84e-05	0.000528	CcSEcCtD
Domperidone—Nausea—Vinorelbine—hematologic cancer	8.84e-05	0.000528	CcSEcCtD
Domperidone—Asthenia—Irinotecan—hematologic cancer	8.8e-05	0.000525	CcSEcCtD
Domperidone—Asthenia—Mitoxantrone—hematologic cancer	8.8e-05	0.000525	CcSEcCtD
Domperidone—Stomatitis—Epirubicin—hematologic cancer	8.74e-05	0.000522	CcSEcCtD
Domperidone—Vomiting—Thalidomide—hematologic cancer	8.74e-05	0.000522	CcSEcCtD
Domperidone—Dizziness—Carmustine—hematologic cancer	8.73e-05	0.000521	CcSEcCtD
Domperidone—Constipation—Etoposide—hematologic cancer	8.73e-05	0.000521	CcSEcCtD
Domperidone—CYP1A2—blood—hematologic cancer	8.72e-05	0.0324	CbGeAlD
Domperidone—Conjunctivitis—Epirubicin—hematologic cancer	8.72e-05	0.00052	CcSEcCtD
Domperidone—Dysuria—Doxorubicin—hematologic cancer	8.7e-05	0.00052	CcSEcCtD
Domperidone—Rash—Thalidomide—hematologic cancer	8.66e-05	0.000517	CcSEcCtD
Domperidone—Dermatitis—Thalidomide—hematologic cancer	8.65e-05	0.000517	CcSEcCtD
Domperidone—Dizziness—Alitretinoin—hematologic cancer	8.64e-05	0.000516	CcSEcCtD
Domperidone—Diarrhoea—Vincristine—hematologic cancer	8.62e-05	0.000515	CcSEcCtD
Domperidone—Headache—Thalidomide—hematologic cancer	8.61e-05	0.000514	CcSEcCtD
Domperidone—Pollakiuria—Doxorubicin—hematologic cancer	8.6e-05	0.000513	CcSEcCtD
Domperidone—Asthenia—Gemcitabine—hematologic cancer	8.57e-05	0.000512	CcSEcCtD
Domperidone—DRD2—testis—hematologic cancer	8.55e-05	0.0318	CbGeAlD
Domperidone—Dizziness—Ifosfamide—hematologic cancer	8.54e-05	0.00051	CcSEcCtD
Domperidone—Pruritus—Gemcitabine—hematologic cancer	8.45e-05	0.000505	CcSEcCtD
Domperidone—Nausea—Thiotepa—hematologic cancer	8.44e-05	0.000504	CcSEcCtD
Domperidone—KCNH2—testis—hematologic cancer	8.42e-05	0.0313	CbGeAlD
Domperidone—CYP3A5—blood—hematologic cancer	8.41e-05	0.0313	CbGeAlD
Domperidone—Oedema—Betamethasone—hematologic cancer	8.4e-05	0.000501	CcSEcCtD
Domperidone—Oedema—Dexamethasone—hematologic cancer	8.4e-05	0.000501	CcSEcCtD
Domperidone—Diarrhoea—Irinotecan—hematologic cancer	8.39e-05	0.000501	CcSEcCtD
Domperidone—Diarrhoea—Mitoxantrone—hematologic cancer	8.39e-05	0.000501	CcSEcCtD
Domperidone—Vomiting—Carmustine—hematologic cancer	8.39e-05	0.000501	CcSEcCtD
Domperidone—Insomnia—Triamcinolone—hematologic cancer	8.37e-05	0.0005	CcSEcCtD
Domperidone—CYP2B6—blood—hematologic cancer	8.36e-05	0.0311	CbGeAlD
Domperidone—Dizziness—Vincristine—hematologic cancer	8.33e-05	0.000497	CcSEcCtD
Domperidone—Rash—Carmustine—hematologic cancer	8.32e-05	0.000497	CcSEcCtD
Domperidone—Dermatitis—Carmustine—hematologic cancer	8.31e-05	0.000496	CcSEcCtD
Domperidone—Vomiting—Alitretinoin—hematologic cancer	8.31e-05	0.000496	CcSEcCtD
Domperidone—Drowsiness—Doxorubicin—hematologic cancer	8.3e-05	0.000495	CcSEcCtD
Domperidone—Headache—Carmustine—hematologic cancer	8.27e-05	0.000494	CcSEcCtD
Domperidone—Rash—Alitretinoin—hematologic cancer	8.24e-05	0.000492	CcSEcCtD
Domperidone—Dermatitis—Alitretinoin—hematologic cancer	8.23e-05	0.000492	CcSEcCtD
Domperidone—Vomiting—Ifosfamide—hematologic cancer	8.21e-05	0.00049	CcSEcCtD
Domperidone—Headache—Alitretinoin—hematologic cancer	8.19e-05	0.000489	CcSEcCtD
Domperidone—Diarrhoea—Gemcitabine—hematologic cancer	8.18e-05	0.000488	CcSEcCtD
Domperidone—Nausea—Thalidomide—hematologic cancer	8.16e-05	0.000487	CcSEcCtD
Domperidone—Dyspepsia—Triamcinolone—hematologic cancer	8.15e-05	0.000486	CcSEcCtD
Domperidone—Rash—Ifosfamide—hematologic cancer	8.15e-05	0.000486	CcSEcCtD
Domperidone—Dermatitis—Ifosfamide—hematologic cancer	8.14e-05	0.000486	CcSEcCtD
Domperidone—Dizziness—Irinotecan—hematologic cancer	8.11e-05	0.000484	CcSEcCtD
Domperidone—Urticaria—Etoposide—hematologic cancer	8.11e-05	0.000484	CcSEcCtD
Domperidone—Stomatitis—Doxorubicin—hematologic cancer	8.09e-05	0.000483	CcSEcCtD
Domperidone—Abdominal pain—Etoposide—hematologic cancer	8.07e-05	0.000482	CcSEcCtD
Domperidone—Conjunctivitis—Doxorubicin—hematologic cancer	8.07e-05	0.000482	CcSEcCtD
Domperidone—Vomiting—Vincristine—hematologic cancer	8.01e-05	0.000478	CcSEcCtD
Domperidone—Urticaria—Prednisolone—hematologic cancer	8e-05	0.000477	CcSEcCtD
Domperidone—Asthenia—Cisplatin—hematologic cancer	7.99e-05	0.000477	CcSEcCtD
Domperidone—Rash—Vincristine—hematologic cancer	7.94e-05	0.000474	CcSEcCtD
Domperidone—Dermatitis—Vincristine—hematologic cancer	7.93e-05	0.000474	CcSEcCtD
Domperidone—Headache—Vincristine—hematologic cancer	7.89e-05	0.000471	CcSEcCtD
Domperidone—Hypotension—Betamethasone—hematologic cancer	7.85e-05	0.000469	CcSEcCtD
Domperidone—Hypotension—Dexamethasone—hematologic cancer	7.85e-05	0.000469	CcSEcCtD
Domperidone—Nausea—Carmustine—hematologic cancer	7.84e-05	0.000468	CcSEcCtD
Domperidone—Vomiting—Irinotecan—hematologic cancer	7.8e-05	0.000466	CcSEcCtD
Domperidone—Vomiting—Mitoxantrone—hematologic cancer	7.8e-05	0.000466	CcSEcCtD
Domperidone—Nausea—Alitretinoin—hematologic cancer	7.76e-05	0.000464	CcSEcCtD
Domperidone—Rash—Mitoxantrone—hematologic cancer	7.73e-05	0.000462	CcSEcCtD
Domperidone—Rash—Irinotecan—hematologic cancer	7.73e-05	0.000462	CcSEcCtD
Domperidone—Dermatitis—Irinotecan—hematologic cancer	7.73e-05	0.000461	CcSEcCtD
Domperidone—Dermatitis—Mitoxantrone—hematologic cancer	7.73e-05	0.000461	CcSEcCtD
Domperidone—CYP2C8—testis—hematologic cancer	7.71e-05	0.0287	CbGeAlD
Domperidone—Headache—Irinotecan—hematologic cancer	7.69e-05	0.000459	CcSEcCtD
Domperidone—Headache—Mitoxantrone—hematologic cancer	7.69e-05	0.000459	CcSEcCtD
Domperidone—Nausea—Ifosfamide—hematologic cancer	7.67e-05	0.000458	CcSEcCtD
Domperidone—CYP1A2—lung—hematologic cancer	7.64e-05	0.0284	CbGeAlD
Domperidone—Diarrhoea—Cisplatin—hematologic cancer	7.62e-05	0.000455	CcSEcCtD
Domperidone—Vomiting—Gemcitabine—hematologic cancer	7.6e-05	0.000454	CcSEcCtD
Domperidone—Insomnia—Betamethasone—hematologic cancer	7.6e-05	0.000453	CcSEcCtD
Domperidone—Insomnia—Dexamethasone—hematologic cancer	7.6e-05	0.000453	CcSEcCtD
Domperidone—Rash—Gemcitabine—hematologic cancer	7.53e-05	0.00045	CcSEcCtD
Domperidone—Dermatitis—Gemcitabine—hematologic cancer	7.53e-05	0.000449	CcSEcCtD
Domperidone—Headache—Gemcitabine—hematologic cancer	7.49e-05	0.000447	CcSEcCtD
Domperidone—Nausea—Vincristine—hematologic cancer	7.48e-05	0.000447	CcSEcCtD
Domperidone—Dyspepsia—Betamethasone—hematologic cancer	7.39e-05	0.000441	CcSEcCtD
Domperidone—Dyspepsia—Dexamethasone—hematologic cancer	7.39e-05	0.000441	CcSEcCtD
Domperidone—CYP3A5—lung—hematologic cancer	7.37e-05	0.0274	CbGeAlD
Domperidone—Urticaria—Triamcinolone—hematologic cancer	7.35e-05	0.000439	CcSEcCtD
Domperidone—CYP2B6—lung—hematologic cancer	7.33e-05	0.0272	CbGeAlD
Domperidone—Asthenia—Etoposide—hematologic cancer	7.32e-05	0.000437	CcSEcCtD
Domperidone—Oedema—Prednisone—hematologic cancer	7.31e-05	0.000437	CcSEcCtD
Domperidone—Nausea—Mitoxantrone—hematologic cancer	7.29e-05	0.000435	CcSEcCtD
Domperidone—Nausea—Irinotecan—hematologic cancer	7.29e-05	0.000435	CcSEcCtD
Domperidone—Pruritus—Etoposide—hematologic cancer	7.22e-05	0.000431	CcSEcCtD
Domperidone—Arrhythmia—Epirubicin—hematologic cancer	7.19e-05	0.000429	CcSEcCtD
Domperidone—Nausea—Gemcitabine—hematologic cancer	7.1e-05	0.000424	CcSEcCtD
Domperidone—Vomiting—Cisplatin—hematologic cancer	7.08e-05	0.000423	CcSEcCtD
Domperidone—Rash—Cisplatin—hematologic cancer	7.02e-05	0.000419	CcSEcCtD
Domperidone—Dermatitis—Cisplatin—hematologic cancer	7.02e-05	0.000419	CcSEcCtD
Domperidone—Diarrhoea—Etoposide—hematologic cancer	6.98e-05	0.000417	CcSEcCtD
Domperidone—CYP2B6—testis—hematologic cancer	6.91e-05	0.0257	CbGeAlD
Domperidone—Tension—Epirubicin—hematologic cancer	6.88e-05	0.000411	CcSEcCtD
Domperidone—Nervousness—Epirubicin—hematologic cancer	6.81e-05	0.000406	CcSEcCtD
Domperidone—Dizziness—Etoposide—hematologic cancer	6.75e-05	0.000403	CcSEcCtD
Domperidone—ABCB1—hematopoietic system—hematologic cancer	6.74e-05	0.0251	CbGeAlD
Domperidone—Muscle spasms—Epirubicin—hematologic cancer	6.74e-05	0.000402	CcSEcCtD
Domperidone—Urticaria—Dexamethasone—hematologic cancer	6.67e-05	0.000398	CcSEcCtD
Domperidone—Urticaria—Betamethasone—hematologic cancer	6.67e-05	0.000398	CcSEcCtD
Domperidone—Dizziness—Prednisolone—hematologic cancer	6.66e-05	0.000397	CcSEcCtD
Domperidone—Arrhythmia—Doxorubicin—hematologic cancer	6.65e-05	0.000397	CcSEcCtD
Domperidone—Asthenia—Triamcinolone—hematologic cancer	6.64e-05	0.000396	CcSEcCtD
Domperidone—Abdominal pain—Dexamethasone—hematologic cancer	6.64e-05	0.000396	CcSEcCtD
Domperidone—Abdominal pain—Betamethasone—hematologic cancer	6.64e-05	0.000396	CcSEcCtD
Domperidone—Nausea—Cisplatin—hematologic cancer	6.62e-05	0.000395	CcSEcCtD
Domperidone—Insomnia—Prednisone—hematologic cancer	6.61e-05	0.000395	CcSEcCtD
Domperidone—Pruritus—Triamcinolone—hematologic cancer	6.55e-05	0.000391	CcSEcCtD
Domperidone—Vomiting—Etoposide—hematologic cancer	6.49e-05	0.000387	CcSEcCtD
Domperidone—Dyspepsia—Prednisone—hematologic cancer	6.44e-05	0.000384	CcSEcCtD
Domperidone—Rash—Etoposide—hematologic cancer	6.43e-05	0.000384	CcSEcCtD
Domperidone—Dermatitis—Etoposide—hematologic cancer	6.43e-05	0.000384	CcSEcCtD
Domperidone—Headache—Etoposide—hematologic cancer	6.39e-05	0.000382	CcSEcCtD
Domperidone—Tension—Doxorubicin—hematologic cancer	6.36e-05	0.00038	CcSEcCtD
Domperidone—Rash—Prednisolone—hematologic cancer	6.35e-05	0.000379	CcSEcCtD
Domperidone—Dermatitis—Prednisolone—hematologic cancer	6.34e-05	0.000379	CcSEcCtD
Domperidone—CYP3A4—blood—hematologic cancer	6.31e-05	0.0235	CbGeAlD
Domperidone—Headache—Prednisolone—hematologic cancer	6.3e-05	0.000376	CcSEcCtD
Domperidone—Nervousness—Doxorubicin—hematologic cancer	6.3e-05	0.000376	CcSEcCtD
Domperidone—Constipation—Prednisone—hematologic cancer	6.25e-05	0.000373	CcSEcCtD
Domperidone—Muscle spasms—Doxorubicin—hematologic cancer	6.23e-05	0.000372	CcSEcCtD
Domperidone—CYP2D6—blood—hematologic cancer	6.21e-05	0.0231	CbGeAlD
Domperidone—Palpitations—Epirubicin—hematologic cancer	6.19e-05	0.00037	CcSEcCtD
Domperidone—Dizziness—Triamcinolone—hematologic cancer	6.12e-05	0.000365	CcSEcCtD
Domperidone—KCNH2—lymph node—hematologic cancer	6.11e-05	0.0227	CbGeAlD
Domperidone—Pipotiazine—SLC22A1—hematologic cancer	6.07e-05	0.437	CrCbGaD
Domperidone—Nausea—Etoposide—hematologic cancer	6.06e-05	0.000362	CcSEcCtD
Domperidone—Asthenia—Dexamethasone—hematologic cancer	6.03e-05	0.00036	CcSEcCtD
Domperidone—Asthenia—Betamethasone—hematologic cancer	6.03e-05	0.00036	CcSEcCtD
Domperidone—Nausea—Prednisolone—hematologic cancer	5.98e-05	0.000357	CcSEcCtD
Domperidone—Pruritus—Dexamethasone—hematologic cancer	5.94e-05	0.000355	CcSEcCtD
Domperidone—Pruritus—Betamethasone—hematologic cancer	5.94e-05	0.000355	CcSEcCtD
Domperidone—Vomiting—Triamcinolone—hematologic cancer	5.88e-05	0.000351	CcSEcCtD
Domperidone—Rash—Triamcinolone—hematologic cancer	5.84e-05	0.000348	CcSEcCtD
Domperidone—Dry mouth—Epirubicin—hematologic cancer	5.84e-05	0.000348	CcSEcCtD
Domperidone—Dermatitis—Triamcinolone—hematologic cancer	5.83e-05	0.000348	CcSEcCtD
Domperidone—Urticaria—Prednisone—hematologic cancer	5.81e-05	0.000347	CcSEcCtD
Domperidone—Headache—Triamcinolone—hematologic cancer	5.8e-05	0.000346	CcSEcCtD
Domperidone—Abdominal pain—Prednisone—hematologic cancer	5.78e-05	0.000345	CcSEcCtD
Domperidone—Diarrhoea—Betamethasone—hematologic cancer	5.75e-05	0.000343	CcSEcCtD
Domperidone—Diarrhoea—Dexamethasone—hematologic cancer	5.75e-05	0.000343	CcSEcCtD
Domperidone—Palpitations—Doxorubicin—hematologic cancer	5.73e-05	0.000342	CcSEcCtD
Domperidone—Oedema—Epirubicin—hematologic cancer	5.72e-05	0.000341	CcSEcCtD
Domperidone—Hypotension—Methotrexate—hematologic cancer	5.71e-05	0.000341	CcSEcCtD
Domperidone—Dizziness—Dexamethasone—hematologic cancer	5.55e-05	0.000332	CcSEcCtD
Domperidone—Dizziness—Betamethasone—hematologic cancer	5.55e-05	0.000332	CcSEcCtD
Domperidone—Insomnia—Methotrexate—hematologic cancer	5.53e-05	0.00033	CcSEcCtD
Domperidone—Nausea—Triamcinolone—hematologic cancer	5.5e-05	0.000328	CcSEcCtD
Domperidone—Somnolence—Methotrexate—hematologic cancer	5.43e-05	0.000324	CcSEcCtD
Domperidone—Dry mouth—Doxorubicin—hematologic cancer	5.4e-05	0.000322	CcSEcCtD
Domperidone—Dyspepsia—Methotrexate—hematologic cancer	5.38e-05	0.000321	CcSEcCtD
Domperidone—Hypotension—Epirubicin—hematologic cancer	5.34e-05	0.000319	CcSEcCtD
Domperidone—Vomiting—Dexamethasone—hematologic cancer	5.34e-05	0.000319	CcSEcCtD
Domperidone—Vomiting—Betamethasone—hematologic cancer	5.34e-05	0.000319	CcSEcCtD
Domperidone—Rash—Betamethasone—hematologic cancer	5.29e-05	0.000316	CcSEcCtD
Domperidone—Rash—Dexamethasone—hematologic cancer	5.29e-05	0.000316	CcSEcCtD
Domperidone—Oedema—Doxorubicin—hematologic cancer	5.29e-05	0.000316	CcSEcCtD
Domperidone—Dermatitis—Dexamethasone—hematologic cancer	5.29e-05	0.000316	CcSEcCtD
Domperidone—Dermatitis—Betamethasone—hematologic cancer	5.29e-05	0.000316	CcSEcCtD
Domperidone—Headache—Dexamethasone—hematologic cancer	5.26e-05	0.000314	CcSEcCtD
Domperidone—Headache—Betamethasone—hematologic cancer	5.26e-05	0.000314	CcSEcCtD
Domperidone—Asthenia—Prednisone—hematologic cancer	5.25e-05	0.000313	CcSEcCtD
Domperidone—Pruritus—Prednisone—hematologic cancer	5.17e-05	0.000309	CcSEcCtD
Domperidone—Insomnia—Epirubicin—hematologic cancer	5.17e-05	0.000309	CcSEcCtD
Domperidone—CYP2D6—testis—hematologic cancer	5.14e-05	0.0191	CbGeAlD
Domperidone—ABCB1—gonad—hematologic cancer	5.13e-05	0.0191	CbGeAlD
Domperidone—Somnolence—Epirubicin—hematologic cancer	5.08e-05	0.000304	CcSEcCtD
Domperidone—Dyspepsia—Epirubicin—hematologic cancer	5.03e-05	0.000301	CcSEcCtD
Domperidone—Diarrhoea—Prednisone—hematologic cancer	5e-05	0.000299	CcSEcCtD
Domperidone—Nausea—Dexamethasone—hematologic cancer	4.99e-05	0.000298	CcSEcCtD
Domperidone—Nausea—Betamethasone—hematologic cancer	4.99e-05	0.000298	CcSEcCtD
Domperidone—Hypotension—Doxorubicin—hematologic cancer	4.95e-05	0.000295	CcSEcCtD
Domperidone—Constipation—Epirubicin—hematologic cancer	4.89e-05	0.000292	CcSEcCtD
Domperidone—Urticaria—Methotrexate—hematologic cancer	4.86e-05	0.00029	CcSEcCtD
Domperidone—Dizziness—Prednisone—hematologic cancer	4.84e-05	0.000289	CcSEcCtD
Domperidone—Abdominal pain—Methotrexate—hematologic cancer	4.83e-05	0.000288	CcSEcCtD
Domperidone—Insomnia—Doxorubicin—hematologic cancer	4.79e-05	0.000286	CcSEcCtD
Domperidone—Somnolence—Doxorubicin—hematologic cancer	4.7e-05	0.000281	CcSEcCtD
Domperidone—Dyspepsia—Doxorubicin—hematologic cancer	4.66e-05	0.000278	CcSEcCtD
Domperidone—Vomiting—Prednisone—hematologic cancer	4.65e-05	0.000278	CcSEcCtD
Domperidone—Rash—Prednisone—hematologic cancer	4.61e-05	0.000275	CcSEcCtD
Domperidone—Dermatitis—Prednisone—hematologic cancer	4.61e-05	0.000275	CcSEcCtD
Domperidone—Headache—Prednisone—hematologic cancer	4.58e-05	0.000274	CcSEcCtD
Domperidone—Urticaria—Epirubicin—hematologic cancer	4.54e-05	0.000271	CcSEcCtD
Domperidone—Constipation—Doxorubicin—hematologic cancer	4.53e-05	0.00027	CcSEcCtD
Domperidone—Abdominal pain—Epirubicin—hematologic cancer	4.52e-05	0.00027	CcSEcCtD
Domperidone—ABCB1—blood—hematologic cancer	4.47e-05	0.0166	CbGeAlD
Domperidone—Asthenia—Methotrexate—hematologic cancer	4.39e-05	0.000262	CcSEcCtD
Domperidone—Nausea—Prednisone—hematologic cancer	4.34e-05	0.000259	CcSEcCtD
Domperidone—Pruritus—Methotrexate—hematologic cancer	4.32e-05	0.000258	CcSEcCtD
Domperidone—ABCB1—bone marrow—hematologic cancer	4.32e-05	0.0161	CbGeAlD
Domperidone—Urticaria—Doxorubicin—hematologic cancer	4.2e-05	0.000251	CcSEcCtD
Domperidone—Abdominal pain—Doxorubicin—hematologic cancer	4.18e-05	0.00025	CcSEcCtD
Domperidone—Diarrhoea—Methotrexate—hematologic cancer	4.18e-05	0.00025	CcSEcCtD
Domperidone—Asthenia—Epirubicin—hematologic cancer	4.1e-05	0.000245	CcSEcCtD
Domperidone—Pruritus—Epirubicin—hematologic cancer	4.05e-05	0.000242	CcSEcCtD
Domperidone—Dizziness—Methotrexate—hematologic cancer	4.04e-05	0.000241	CcSEcCtD
Domperidone—ABCB1—lung—hematologic cancer	3.92e-05	0.0146	CbGeAlD
Domperidone—Diarrhoea—Epirubicin—hematologic cancer	3.91e-05	0.000234	CcSEcCtD
Domperidone—Vomiting—Methotrexate—hematologic cancer	3.89e-05	0.000232	CcSEcCtD
Domperidone—Rash—Methotrexate—hematologic cancer	3.85e-05	0.00023	CcSEcCtD
Domperidone—Dermatitis—Methotrexate—hematologic cancer	3.85e-05	0.00023	CcSEcCtD
Domperidone—Headache—Methotrexate—hematologic cancer	3.83e-05	0.000229	CcSEcCtD
Domperidone—Asthenia—Doxorubicin—hematologic cancer	3.8e-05	0.000227	CcSEcCtD
Domperidone—Dizziness—Epirubicin—hematologic cancer	3.78e-05	0.000226	CcSEcCtD
Domperidone—Pruritus—Doxorubicin—hematologic cancer	3.74e-05	0.000224	CcSEcCtD
Domperidone—ABCB1—testis—hematologic cancer	3.7e-05	0.0137	CbGeAlD
Domperidone—Vomiting—Epirubicin—hematologic cancer	3.64e-05	0.000217	CcSEcCtD
Domperidone—Nausea—Methotrexate—hematologic cancer	3.63e-05	0.000217	CcSEcCtD
Domperidone—Diarrhoea—Doxorubicin—hematologic cancer	3.62e-05	0.000216	CcSEcCtD
Domperidone—Rash—Epirubicin—hematologic cancer	3.61e-05	0.000215	CcSEcCtD
Domperidone—Dermatitis—Epirubicin—hematologic cancer	3.6e-05	0.000215	CcSEcCtD
Domperidone—Headache—Epirubicin—hematologic cancer	3.58e-05	0.000214	CcSEcCtD
Domperidone—Dizziness—Doxorubicin—hematologic cancer	3.5e-05	0.000209	CcSEcCtD
Domperidone—Nausea—Epirubicin—hematologic cancer	3.4e-05	0.000203	CcSEcCtD
Domperidone—Vomiting—Doxorubicin—hematologic cancer	3.37e-05	0.000201	CcSEcCtD
Domperidone—Rash—Doxorubicin—hematologic cancer	3.34e-05	0.000199	CcSEcCtD
Domperidone—Dermatitis—Doxorubicin—hematologic cancer	3.33e-05	0.000199	CcSEcCtD
Domperidone—Headache—Doxorubicin—hematologic cancer	3.32e-05	0.000198	CcSEcCtD
Domperidone—Nausea—Doxorubicin—hematologic cancer	3.14e-05	0.000188	CcSEcCtD
Domperidone—ABCB1—lymph node—hematologic cancer	2.68e-05	0.00996	CbGeAlD
Domperidone—Pimozide—ABCB1—hematologic cancer	2.05e-05	0.147	CrCbGaD
Domperidone—Nefazodone—ABCB1—hematologic cancer	2.04e-05	0.147	CrCbGaD
Domperidone—Trazodone—ABCB1—hematologic cancer	1.88e-05	0.136	CrCbGaD
Domperidone—Pipotiazine—ALB—hematologic cancer	1.85e-05	0.133	CrCbGaD
Domperidone—DRD3—Signaling by GPCR—MAPK3—hematologic cancer	4.37e-06	7.39e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.36e-06	7.38e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.35e-06	7.36e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CREB1—hematologic cancer	4.34e-06	7.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.34e-06	7.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—TXN—hematologic cancer	4.34e-06	7.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.34e-06	7.35e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYCS—hematologic cancer	4.3e-06	7.27e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.3e-06	7.27e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—BRAF—hematologic cancer	4.29e-06	7.26e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NQO1—hematologic cancer	4.28e-06	7.24e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CD44—hematologic cancer	4.28e-06	7.24e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.27e-06	7.22e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SDC1—hematologic cancer	4.26e-06	7.21e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCL2—hematologic cancer	4.25e-06	7.19e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.25e-06	7.19e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6R—hematologic cancer	4.24e-06	7.17e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CREBBP—hematologic cancer	4.23e-06	7.16e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.21e-06	7.12e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2RA—hematologic cancer	4.19e-06	7.09e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—MTHFR—hematologic cancer	4.17e-06	7.06e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CD—hematologic cancer	4.17e-06	7.05e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—hematologic cancer	4.16e-06	7.04e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TERT—hematologic cancer	4.14e-06	7.01e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.12e-06	6.96e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ALB—hematologic cancer	4.11e-06	6.96e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.08e-06	6.91e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—MTHFR—hematologic cancer	4.08e-06	6.9e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.07e-06	6.89e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYCS—hematologic cancer	4.05e-06	6.85e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PDGFB—hematologic cancer	4.05e-06	6.84e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAP2K1—hematologic cancer	4.04e-06	6.83e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.02e-06	6.81e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.02e-06	6.8e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CD—hematologic cancer	4.01e-06	6.79e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—NCOR1—hematologic cancer	4e-06	6.76e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—hematologic cancer	4e-06	6.76e-05	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PIK3CA—hematologic cancer	3.97e-06	6.72e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.97e-06	6.72e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.97e-06	6.72e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TSC2—hematologic cancer	3.95e-06	6.69e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.93e-06	6.66e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—KRAS—hematologic cancer	3.93e-06	6.64e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.87e-06	6.55e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.85e-06	6.51e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—FGF2—hematologic cancer	3.84e-06	6.5e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGFR3—hematologic cancer	3.8e-06	6.43e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—hematologic cancer	3.79e-06	6.41e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3R1—hematologic cancer	3.79e-06	6.41e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK14—hematologic cancer	3.77e-06	6.37e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NUP98—hematologic cancer	3.75e-06	6.34e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ESR1—hematologic cancer	3.69e-06	6.25e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—JAK2—hematologic cancer	3.68e-06	6.23e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FN1—hematologic cancer	3.65e-06	6.17e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.64e-06	6.16e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.64e-06	6.16e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.63e-06	6.14e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NQO1—hematologic cancer	3.63e-06	6.13e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CD44—hematologic cancer	3.63e-06	6.13e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NUP214—hematologic cancer	3.61e-06	6.11e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CA—hematologic cancer	3.61e-06	6.1e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BAD—hematologic cancer	3.61e-06	6.1e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	3.61e-06	6.1e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MDM2—hematologic cancer	3.59e-06	6.08e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	3.57e-06	6.04e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.57e-06	6.04e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.55e-06	6.01e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTR—hematologic cancer	3.54e-06	5.99e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.54e-06	5.99e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.53e-06	5.97e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.51e-06	5.93e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CD80—hematologic cancer	3.5e-06	5.92e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CB—hematologic cancer	3.5e-06	5.92e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MTOR—hematologic cancer	3.5e-06	5.92e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KIT—hematologic cancer	3.49e-06	5.91e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	3.49e-06	5.91e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—NRAS—hematologic cancer	3.49e-06	5.91e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—NCOR1—hematologic cancer	3.48e-06	5.89e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—hematologic cancer	3.48e-06	5.89e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ENO2—hematologic cancer	3.47e-06	5.87e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYCS—hematologic cancer	3.43e-06	5.8e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTPN11—hematologic cancer	3.43e-06	5.8e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.43e-06	5.8e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.41e-06	5.77e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.38e-06	5.72e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.37e-06	5.7e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	3.34e-06	5.66e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—HRAS—hematologic cancer	3.34e-06	5.65e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CREB1—hematologic cancer	3.32e-06	5.62e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SDC1—hematologic cancer	3.29e-06	5.57e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BRAF—hematologic cancer	3.28e-06	5.55e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1B—hematologic cancer	3.28e-06	5.55e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.28e-06	5.55e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.28e-06	5.55e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCL2—hematologic cancer	3.25e-06	5.5e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CREBBP—hematologic cancer	3.25e-06	5.5e-05	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—AKT1—hematologic cancer	3.25e-06	5.49e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6R—hematologic cancer	3.24e-06	5.48e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CREBBP—hematologic cancer	3.24e-06	5.48e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CASP3—hematologic cancer	3.22e-06	5.44e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—hematologic cancer	3.21e-06	5.43e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL6—hematologic cancer	3.2e-06	5.41e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.18e-06	5.37e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—hematologic cancer	3.14e-06	5.31e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—hematologic cancer	3.13e-06	5.3e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—JUN—hematologic cancer	3.12e-06	5.28e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.11e-06	5.26e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	3.09e-06	5.23e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CD—hematologic cancer	3.08e-06	5.21e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—MTHFR—hematologic cancer	3.08e-06	5.2e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	3.07e-06	5.19e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.07e-06	5.19e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ALB—hematologic cancer	3.04e-06	5.15e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	3.04e-06	5.14e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1A—hematologic cancer	3.03e-06	5.12e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.02e-06	5.12e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—hematologic cancer	3.02e-06	5.11e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	3.01e-06	5.09e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KRAS—hematologic cancer	3.01e-06	5.08e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—EP300—hematologic cancer	2.99e-06	5.06e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ALB—hematologic cancer	2.97e-06	5.03e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.97e-06	5.02e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK8—hematologic cancer	2.96e-06	5e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—AKT1—hematologic cancer	2.95e-06	4.99e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FGF2—hematologic cancer	2.94e-06	4.97e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.93e-06	4.95e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.91e-06	4.92e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.9e-06	4.9e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	2.9e-06	4.9e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—EP300—hematologic cancer	2.88e-06	4.87e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.86e-06	4.84e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.84e-06	4.81e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JAK2—hematologic cancer	2.82e-06	4.77e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—SRC—hematologic cancer	2.8e-06	4.74e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NQO1—hematologic cancer	2.8e-06	4.73e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CD44—hematologic cancer	2.8e-06	4.73e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.78e-06	4.7e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.78e-06	4.7e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	2.76e-06	4.67e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.75e-06	4.65e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MDM2—hematologic cancer	2.75e-06	4.65e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—hematologic cancer	2.73e-06	4.62e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—STAT3—hematologic cancer	2.7e-06	4.57e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—NRAS—hematologic cancer	2.7e-06	4.56e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.69e-06	4.54e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	2.68e-06	4.53e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MTOR—hematologic cancer	2.68e-06	4.53e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYCS—hematologic cancer	2.65e-06	4.48e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.63e-06	4.45e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.63e-06	4.44e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.61e-06	4.41e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.59e-06	4.37e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK3—hematologic cancer	2.58e-06	4.37e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ALB—hematologic cancer	2.58e-06	4.36e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—HRAS—hematologic cancer	2.55e-06	4.32e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	2.51e-06	4.25e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—hematologic cancer	2.51e-06	4.25e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TGFB1—hematologic cancer	2.51e-06	4.24e-05	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	2.48e-06	4.2e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.46e-06	4.17e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CASP3—hematologic cancer	2.46e-06	4.16e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—hematologic cancer	2.46e-06	4.16e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.46e-06	4.15e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL6—hematologic cancer	2.45e-06	4.14e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.44e-06	4.12e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CREBBP—hematologic cancer	2.4e-06	4.05e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—hematologic cancer	2.4e-06	4.05e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JUN—hematologic cancer	2.39e-06	4.04e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.33e-06	3.95e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—hematologic cancer	2.32e-06	3.93e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KRAS—hematologic cancer	2.32e-06	3.92e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	2.32e-06	3.92e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—hematologic cancer	2.31e-06	3.91e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.27e-06	3.85e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.27e-06	3.84e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—hematologic cancer	2.27e-06	3.84e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK8—hematologic cancer	2.26e-06	3.83e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.26e-06	3.82e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—AKT1—hematologic cancer	2.26e-06	3.82e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ALB—hematologic cancer	2.24e-06	3.79e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.21e-06	3.74e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—EP300—hematologic cancer	2.21e-06	3.74e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.21e-06	3.74e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EP300—hematologic cancer	2.21e-06	3.73e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.16e-06	3.66e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—EP300—hematologic cancer	2.16e-06	3.66e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.15e-06	3.63e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.15e-06	3.63e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.15e-06	3.63e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—SRC—hematologic cancer	2.14e-06	3.63e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.14e-06	3.62e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	2.13e-06	3.61e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ALB—hematologic cancer	2.11e-06	3.58e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—hematologic cancer	2.09e-06	3.53e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—STAT3—hematologic cancer	2.07e-06	3.5e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.06e-06	3.49e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—NRAS—hematologic cancer	2.06e-06	3.49e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—hematologic cancer	2.06e-06	3.49e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.02e-06	3.42e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.98e-06	3.35e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.98e-06	3.34e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HRAS—hematologic cancer	1.97e-06	3.34e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—hematologic cancer	1.96e-06	3.32e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—hematologic cancer	1.92e-06	3.25e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TGFB1—hematologic cancer	1.92e-06	3.24e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.91e-06	3.24e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.9e-06	3.21e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL6—hematologic cancer	1.89e-06	3.19e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—EP300—hematologic cancer	1.87e-06	3.17e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.87e-06	3.16e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.81e-06	3.07e-05	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.81e-06	3.06e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALB—hematologic cancer	1.79e-06	3.03e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.78e-06	3e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—AKT1—hematologic cancer	1.74e-06	2.95e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.71e-06	2.9e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—hematologic cancer	1.71e-06	2.9e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.64e-06	2.77e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—EP300—hematologic cancer	1.63e-06	2.76e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.63e-06	2.76e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.61e-06	2.73e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.6e-06	2.71e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.59e-06	2.69e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.58e-06	2.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—hematologic cancer	1.58e-06	2.67e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—EP300—hematologic cancer	1.54e-06	2.6e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.51e-06	2.55e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.48e-06	2.5e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL6—hematologic cancer	1.44e-06	2.44e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.4e-06	2.37e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.39e-06	2.34e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALB—hematologic cancer	1.38e-06	2.34e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—hematologic cancer	1.37e-06	2.31e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—AKT1—hematologic cancer	1.34e-06	2.26e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.33e-06	2.25e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.32e-06	2.24e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—AKT1—hematologic cancer	1.31e-06	2.21e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—EP300—hematologic cancer	1.3e-06	2.2e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.22e-06	2.06e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.21e-06	2.04e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.14e-06	1.92e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—AKT1—hematologic cancer	1.13e-06	1.92e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.05e-06	1.78e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—EP300—hematologic cancer	1.01e-06	1.7e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—AKT1—hematologic cancer	9.87e-07	1.67e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.64e-07	1.63e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—AKT1—hematologic cancer	9.3e-07	1.57e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—AKT1—hematologic cancer	7.88e-07	1.33e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.44e-07	1.26e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—AKT1—hematologic cancer	6.08e-07	1.03e-05	CbGpPWpGaD
